138 related articles for article (PubMed ID: 35686812)
1. A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information System.
Millan B; Breau RH; Bhindi B; Mallick R; Tanguay S; Finelli A; Lavallée LT; Pouliot F; Rendon R; So AI; Dean L; Lattouf JB; Basappa NS; Kapoor A
J Urol; 2022 Oct; 208(4):804-812. PubMed ID: 35686812
[TBL] [Abstract][Full Text] [Related]
2. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study-UroCCR 71).
Brassier M; Khene ZE; Bernhard JC; Dang VT; Ouzaid I; Nouhaud FX; Olivier J; Nedelcu C; Grenier N; Beuzit L; Doumerc N; Bensalah K; Bigot P;
Eur Urol Focus; 2022 Jan; 8(1):210-216. PubMed ID: 33622625
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
5. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
6. Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
Shi L; He Y; Liu C; Qian X; Wang Z
Cancer Med; 2020 Nov; 9(21):7988-8003. PubMed ID: 32888392
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
Uhlig A; Uhlig J; Trojan L; Kim HS
J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
[TBL] [Abstract][Full Text] [Related]
8. Recurrence after radical and partial nephrectomy in high complex renal tumor using propensity score matched analysis.
Kim H; Kim JK; Ye C; Choi JH; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
Sci Rep; 2021 Feb; 11(1):2919. PubMed ID: 33536492
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis.
Chang X; Liu T; Zhang F; Ji C; Zhao X; Wang W; Guo H
J Endourol; 2015 May; 29(5):518-25. PubMed ID: 25556579
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
Rembeyo G; Correas JM; Jantzen R; Audenet F; Dariane C; Delavaud C; Mejean A; Timsit MO
Clin Genitourin Cancer; 2020 Apr; 18(2):138-147. PubMed ID: 31982346
[TBL] [Abstract][Full Text] [Related]
11. Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis.
Yanagisawa T; Mori K; Kawada T; Motlagh RS; Mostafaei H; Quhal F; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Pradere B; Miki J; Kimura T; Egawa S; Shariat SF
Urol Oncol; 2022 Jul; 40(7):315-330. PubMed ID: 35562311
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous ablation or minimally invasive partial nephrectomy for cT1a renal masses? A propensity score-matched analysis.
Bianchi L; Chessa F; Piazza P; Ercolino A; Mottaran A; Recenti D; Serra C; Gaudiano C; Cappelli A; Modestino F; Golfieri R; Bertaccini A; Marcelli E; Porreca A; Celia A; Schiavina R
Int J Urol; 2022 Mar; 29(3):222-228. PubMed ID: 34894001
[TBL] [Abstract][Full Text] [Related]
13. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
[TBL] [Abstract][Full Text] [Related]
14. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
15. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery.
Shapiro DD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Jarrard DF; Richards KA; Downs TM; Allen GO; Nakada SY; Abel EJ
Urology; 2020 Jan; 135():88-94. PubMed ID: 31585198
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
17. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
[TBL] [Abstract][Full Text] [Related]
18. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass.
Mason RJ; Atwell TD; Lohse C; Bhindi B; Weisbrod A; Boorjian SA; Leibovich BC; Schmit GD; Thompson RH
BJU Int; 2017 Oct; 120(4):544-549. PubMed ID: 28548236
[TBL] [Abstract][Full Text] [Related]
19. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
20. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
